Last month, Softbank, through its massive Vision Fund, led the single biggest private financing round for a health care company ever — funneling $1.1 billion into the drug holding outfit Roivant Sciences. Today, the Japanese conglomerate might be regretting that decision. The reason: despite hundreds of millions of dollars poured into one of Roivant’s publicly traded… Read More
from iFeeltech IT News Mix4 https://techcrunch.com/2017/09/26/roivant-receives-bad-news-and-so-does-softbank/?ncid=rss
from
https://ifeeltechinc.wordpress.com/2017/09/26/roivant-receives-bad-news-and-so-does-softbank/
No comments:
Post a Comment